- $35.82m
- $33.92m
- $24.05m
Brief: Precipio Inc Announces Pricing Of $2 Mln Registered Direct Offering And Concurrent Private Placement
Precipio Inc expected to post a loss of 11 cents a share - Earnings Preview
Precipio Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: Precipio Granted 180-Day Extension From Nasdaq To Regain Compliance
Precipio Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Precipio Signs Another Major Hemescreen Customer
Precipio Inc reports results for the quarter ended in September - Earnings Summary
Brief: Precipio To Distribute Hemescreen® Through Fisher Healthcare Channel
Brief: Precipio Receives CE-IVD Certification To Market Multiple Hemescreen® Panels In Europe
Brief: Precipio Signs First Iv-Cell Customer Agreement
Brief: Precipio Announces Resignation Of Chief Financial Officer And Appointment Of Interim CFO
Brief: New York State Approves Precipio’S Hemescreen For POL Clinical Use
Precipio Inc reports results for the quarter ended in June - Earnings Summary
mRNA cos up after Sanofi snaps up Translate Bio in $3.2 bln deal
Brief: Precipio Announces Preliminary Unaudited Q2-2021 Revenues Of $2.3 Mln
Brief: Precipio Terminates Its Equity Line
Brief: Precipio Launches Hemescreen Anemia Panel, A One-Of-Its-Kind Testing Tool
Precipio Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Hyrecar, Plantronics, Walt Disney